MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647127215 A) filed by Nippon Shinyaku Co. , Ltd. on October 26, 2026, for Compound Capable Of Inhibiting Binding Between Cug Repeat Rna And Mbnl Protein, And Medicine.
Inventors include Akiyama Satoshi; Haruta Yoshinari; Yamanaka Takuto; Kodani Atsushi; and Miyagawa Takero.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Provided is a compound represented by general formula (1) [wherein X1, X2 and X3 each independently represent -CH= or the like; A represents -O- or the like; B represents a single bond, a C1-C5 alkylene group, or the like; C represents a substituted or unsubstituted nitrogen-containing heterocyclic group or the like; and at least one of B and C contains one or more nitrogen atoms], or a pharmaceutically acceptable salt of the compound, or a solvate of the compound or the pharmaceutically acceptable salt.
Disclaimer: Curated by HT Syndication.
